The Korea Food and Drug Administration's (KFDA) Drug Evaluation Institute announced on the 22nd that its self-developed alternative animal testing method has been registered as an international standard by the International Organization for Standardization (ISO). This testing method evaluates skin irritation of medical devices using a human skin model. The KFDA expects to reduce the time for skin irritation testing and save on expenses.
HK inno.N announced on the 22nd that it will introduce its hangover remedy "Condition Zero Sparkling." The product reduces calorie burden with an alternative sugar excreted from the body. The concentrate and sparkling water created a refreshing feel. The company has developed five product lines: Condition, Condition Lady, Condition CEO, Condition Stick, and Condition Zero Sparkling.
Dong-A Pharmaceutical announced on the 22nd that it will hold a "Love Sharing Bazaar" for local residents in Dongdaemun-gu at its headquarters outdoor parking lot on the 29th. It will sell Bacchus, Pocari Sweat, health functional foods, animal nutritional supplements, daily goods, and cosmetics from Dong-A Pharmaceutical and Dong-A Otsuka at affordable prices. The revenue will be donated to the Dongdaemun District Social Welfare Council to help low-income and marginalized individuals. Dong-A Pharmaceutical has been holding bazaars since 2009 to promote a culture of giving.
AstraZeneca Korea announced on the 22nd that it is enhancing collaboration on clinical trials with Severance Hospital. It provides innovative treatment opportunities for patients with chronic diseases, rare diseases, and cancer. AstraZeneca Korea will design clinical trial protocols and share them with Severance Hospital.
Seoul National University Hospital announced on the 22nd that Professor Lee Eun-young from the Department of Rheumatology received the "2025 Korean Rheumatology Academic Award" at the Korean Rheumatism Association's spring academic conference. This award is given to researchers with outstanding achievements in rheumatology research. Professor Lee has improved diagnostic and treatment methods for rheumatism and autoimmune diseases. She said, "I will provide better treatment for patients."